The Challenges and Therapeutic Prospects in Cardiovascular Disease
A special issue of Journal of Personalized Medicine (ISSN 2075-4426). This special issue belongs to the section "Mechanisms of Diseases".
Deadline for manuscript submissions: 20 February 2025 | Viewed by 125
Special Issue Editor
Interests: cardiovascular disease; coronary artery disease; coronary microvascular dysfunction; percutaneous coronary intervention; cardiovascular prevention; hypercholesterolemia
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Cardiovascular diseases (CVD) are a leading global cause of mortality and are primarily driven by atherosclerotic coronary artery disease. Their pathogenesis involves multi-factorial mechanisms, among which coronary artery disease plays a causative role. Cardiology represents an area of highly innovative medicine based on new diagnostic strategies, new therapies, and cutting-edge pharmacological and interventional technologies. Today, pathologies such as heart failure, arterial hypertension, and hypercholesterolemia have increasingly effective therapies. This Special Issue aims to provide an overview of the latest challenges in diagnosis and new therapeutic prospects in cardiovascular disease.
In this Special Issue, we welcome original research and review articles regarding new challenges and therapies for cardiovascular diseases.
Dr. Vincenzo Sucato
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Personalized Medicine is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- cardiovascular disease
- coronary artery disease
- coronary microvascular dysfunction
- percutaneous coronary intervention
- cardiomyopathy
- cardiovascular prevention
- heart failure
- hypercholesterolemia
- residual cardiovascular risk
- cardioncology
